led by global experts with deep industry experience
Hybrid Blend of In-Person and Remote Sessions
helps you balance your schedule
without sacrificing learning quality
SciCellerate's 3-Step Learning Process
Scilentia's approach to educating SciCellerate cohort participants is
firmly anchored in a successful
3-step approach to adult learning
Fundamentals 101, Learning from Experts about the Basics of Taking a Drug from Laboratory...
Scilentia's expert faculty members teach you the realities of the complex steps required to get from a drug target shaped up and ready for an IND and beyond.
You will interact with top executives from Fortune 10 pharmas and high growth biotechs who have successfully advanced candidates from the bench, to the clinic and to launch.
You will learn about the realities of the process during interactive, in-person and remote learning sessions where you, your faculty expert and your fellow cohort participants will debate, discuss and deconstruct the key steps along the path from IND to FDA approval and finally, launch.
Case Study Work in Partnership with other Cohort Participants
Case studies and actual use cases, drawn from start-up, biotech and pharma industry challenges and successes form the framework of this portion of your Scilentia program.
You will work in small groups with individuals from other startups who are part of your cohort to test your thinking, share best practices, and design a "typical" drug discovery, development and commercialization plan.
Comparing your decisions against those that were actually made by the teams responsible for the real-life drug candidate or asset will give you the foundation for the next stage of the Scilentia process: building your startup's plan of action, aided by Scilentia Global Partners and faculty experts.
Dedicated Time and Resources to Finalize Your Startup's Discovery, Development and Commercialization Plans
You'll work closely with your assigned Scilentia Global Partner and the experts who have led you through the program to craft an optimized strategy for your organization's drug candidate.
This critical document is the foundational input to your pitch deck, your communications with investors and even your social media efforts.
You'll leave the program confident and secure, with a fully articulated, polished plan of action that is ready for even the most challenging of external stakeholders.